Product NDC: | 57664-273 |
Proprietary Name: | CLONAZEPAM |
Non Proprietary Name: | CLONAZEPAM |
Active Ingredient(s): | .5 mg/1 & nbsp; CLONAZEPAM |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 57664-273 |
Labeler Name: | Caraco Pharmaceutical Laboratories, Ltd. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075423 |
Marketing Category: | ANDA |
Start Marketing Date: | 20010831 |
Package NDC: | 57664-273-08 |
Package Description: | 100 TABLET in 1 BOTTLE (57664-273-08) |
NDC Code | 57664-273-08 |
Proprietary Name | CLONAZEPAM |
Package Description | 100 TABLET in 1 BOTTLE (57664-273-08) |
Product NDC | 57664-273 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CLONAZEPAM |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20010831 |
Marketing Category Name | ANDA |
Labeler Name | Caraco Pharmaceutical Laboratories, Ltd. |
Substance Name | CLONAZEPAM |
Strength Number | .5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |